Main Menu

china practice

PDF

MSK’s China Practice was established primarily to guide Chinese companies interested in doing business in the United States. Whether their needs involve accessing U.S. capital markets, establishing corporate governance, securing immigration visas, managing their intellectual property portfolio, or navigating complex tax treatment, our attorneys have the depth of expertise necessary that comes from being one of the most active firms in the Country.

We focus on structuring and financing of China-based businesses, cross-border mergers, acquisitions, and the representation of Chinese companies investing in and doing business in the U.S.. Our attorneys understand and appreciate the business and legal aspects of U.S.-China transactions across multiple industries. We have a deep understanding of how China-based businesses are formed, financed, grown and taken public or acquired.

MSK has also leveraged its rolodex of relationships in the U.S. to assist Chinese companies seeking to consummate transactions with U.S. companies. We also have a network of relationships with leading Chinese law, accounting, and venture capital firms.

We regularly advise clients in the following areas:

  • Formation and financing of Chinese companies 

  • Company and acquirer side representations in M&A transactions

  • Structuring tax and other aspects of U.S.-China transactions

  • Advising Chinese companies on U.S. capital markets transactions

  • Securing immigration visas for executives and investors

  • Representing Chinese companies and investors in entertainment-related transactions

  • Real estate development projects

Led by a team that has decades’ experience serving Chinese clients, our attorneys have the skill sets, cultural understandings, and relationships to effectively influence our Chinese clients.

Spotlight

  • Real Estate - #1 Los Angeles county ranking for foreign investment in California
  • Real Estate - $31.7 billion from Chinese buyers in real estate between April 2016 and March 2017
  • Regulatory - 40% collective GDP impacted by Transpacific Trade Partnership

中文

Navigating the complexities of U.S. capital markets, adequately preparing for the increasing burdens of various regulatory bodies, and effectively establishing relationships with influencers in a $17 trillion U.S. economy is difficult in the best of circumstances. But when you arrive from foreign shores it can be almost paralyzing. For decades, MSK has been assisting companies in China access U.S. markets in a variety of ways. From the earliest days of the developing trends of capitalism in China, MSK has been at the forefront of providing legal and business counsel to some of the fastest growing Chinese companies as they enter the U.S. economy.

Headlines

Practice Chairs

Back to Page